• Flanders Investment & Trade
  • Team Vesalius

Holding a doctorate in biological sciences, evolutionary biologist Karina Van Doninck went to obtain postdoctorates at Harvard University and the University of Montpellier.

Karine Van Doninck


Avenue Franklin Roosevelt 50
1050 Bruxelles

At 30, Van Doninck became a professor at the University of Namur, where she combined teaching with fundamental research in evolutionary biology. Her groundbreaking research focuses on microscopic species that will soon be sent to space as part of a European Space Agency project.

In 2017, Van Doninck was the first and only woman in Belgium to receive a prestigious grant from the European Research Council (ERC). Additionally, ranks among Charlie's Top 25 Influential Belgians in the World. Since 2020, Van Doninck has been a professor at the ULB, where she will start a new research group in molecular biology and evolution. 

Team Vesalius visionairies

Flanders’ life sciences industry: the perfect combo of biotech, medtech, pharma and healthcare

Defining Flanders’ life sciences industry as diverse is an understatement. From young start-ups to established local firms and multinationals: the entire value chain – from research and discovery to development and commercialization – is represented in Belgium’s northern region. Thanks to fertile cross-pollination between biotech, medtech, pharmaceuticals and healthcare, Flanders offers a unique life sciences ecosystem that is underpinned by a robust financing landscape and a supportive government. Will your company claim its place in this dynamic hub?